论文部分内容阅读
目的:对兰索拉唑联合胃苏颗粒治疗反流性食管炎患者的临床效果进行探讨。方法:选取2012年4月-2013年4月在我院接受治疗的107例反流性食管炎患者作为研究对象,所有患者均经胃镜检查确诊,运用随机双盲法将其分为观察组(54例)和对照组(53例),对照组患者给予兰索拉唑联合莫沙必利治疗,观察组患者给予兰索拉唑联合胃苏颗粒治疗。结果:观察组患者的治疗总有效率与对照组相比(p<0.05);观察组患者的不良反应发生率显著低于对照组(p<0.05)。结论:米索拉唑联合胃苏颗粒治疗反流性食管炎患者能够提高治疗有效率,降低不良反应率,可在临床广泛推广。
Objective: To investigate the clinical effect of lansoprazole combined with Weisu particles in the treatment of patients with reflux esophagitis. Methods: A total of 107 patients with reflux esophagitis treated in our hospital from April 2012 to April 2013 were enrolled in this study. All patients were diagnosed by gastroscopy and divided into observation group 54 cases) and control group (53 cases). Patients in the control group were treated with lansoprazole combined with mosapride and patients in the observation group were given lansoprazole combined with weisu particles. Results: The total effective rate of the observation group was significantly lower than that of the control group (p <0.05). The incidence of adverse reactions in the observation group was significantly lower than that of the control group (p <0.05). Conclusion: The combination of misoprostol and stomach Su particles in patients with reflux esophagitis can improve the treatment efficiency and reduce the adverse reaction rate, which can be widely applied in clinic.